Regen BioPharma Inc
(OTCPK:RGBP)
$
0.28
0.07459 (36.31%)
Market Cap: 1.26 Mil
Enterprise Value: 1.58 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 35/100 Regen BioPharma Inc To Present at the Emerging Growth Conference Transcript
Nov 09, 2022 / 06:45PM GMT
Release Date Price:
$7.95
(-9.40%)
Ana Berry
EmergingGrowth.com - Moderator
Welcome back, everyone. What a great conference we've had. Today, let's welcome our next presenter. We have Regen BioPharma, Inc. It trades on the OTC Pink Sheets under the symbol RGBP and RGBPP. And it's focused currently on mRNA and small molecule therapies for treating cancer and autoimmune disorders.
Please welcome its President and CEO, David Koos; and Chief Scientific Consultant, Harry lander. Welcome, gentlemen.
David Koos
Regen BioPharma, Inc. - President, Chairman & CEO
All right. Thank you very much. We're happy to be here.
Ana Berry
EmergingGrowth.com - Moderator
Take it away.
David Koos
Regen BioPharma, Inc. - President, Chairman & CEO
Okay. So I'm David Koos. I'm the CEO of the company.
On our slide deck, the first slide, I'd like everybody to take a quick peek at is our Safe Harbor slide. As a public company, we're required to disclose the Safe Harbor provisions. And then we'll go on
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot